“Real-Time” High-Throughput Drug and Synergy Testing for Multidrug-Resistant Bacterial Infection: A Case Report
Antibiotic management of infections with multidrug-resistant organisms (MDRO) represents a complex clinical challenge. We report here the first patient with a severe MDRO infection managed with assistance of a novel “real-time” 3-day high-throughput screen (HTS) that allowed screening of 9 drugs in...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-09-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2018.00267/full |
id |
doaj-ee63eb18bade46dab7fac03f184271fa |
---|---|
record_format |
Article |
spelling |
doaj-ee63eb18bade46dab7fac03f184271fa2020-11-24T21:26:10ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2018-09-01510.3389/fmed.2018.00267412539“Real-Time” High-Throughput Drug and Synergy Testing for Multidrug-Resistant Bacterial Infection: A Case ReportWei Sun0Shayla Hesse1Miao Xu2Richard W. Childs3Wei Zheng4Peter R. Williamson5National Center for Advancing Translational Sciences, Bethesda, MD, United StatesLaboratory of Molecular Biology, National Cancer Institute, Bethesda, MD, United StatesNational Center for Advancing Translational Sciences, Bethesda, MD, United StatesTransplantation Immunotherapy, Hematology Branch, National Heart Lung and Blood Institute, Bethesda, MD, United StatesNational Center for Advancing Translational Sciences, Bethesda, MD, United StatesLaboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United StatesAntibiotic management of infections with multidrug-resistant organisms (MDRO) represents a complex clinical challenge. We report here the first patient with a severe MDRO infection managed with assistance of a novel “real-time” 3-day high-throughput screen (HTS) that allowed screening of 9 drugs in 14 combinations in 2,304 total samplings. Identified synergies were used to modify patient therapy with the goal of reducing drug-induced toxicity. The desired clinical outcome was achieved on the HTS-informed therapeutic regimen, supporting the utility of HTS technology to expand standard antimicrobial susceptibility testing.https://www.frontiersin.org/article/10.3389/fmed.2018.00267/fullmultidrug-resistant organismsKlebsiella pneumoniaereal-time drug testantibiotic combination therapydrug repurposing screen |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Wei Sun Shayla Hesse Miao Xu Richard W. Childs Wei Zheng Peter R. Williamson |
spellingShingle |
Wei Sun Shayla Hesse Miao Xu Richard W. Childs Wei Zheng Peter R. Williamson “Real-Time” High-Throughput Drug and Synergy Testing for Multidrug-Resistant Bacterial Infection: A Case Report Frontiers in Medicine multidrug-resistant organisms Klebsiella pneumoniae real-time drug test antibiotic combination therapy drug repurposing screen |
author_facet |
Wei Sun Shayla Hesse Miao Xu Richard W. Childs Wei Zheng Peter R. Williamson |
author_sort |
Wei Sun |
title |
“Real-Time” High-Throughput Drug and Synergy Testing for Multidrug-Resistant Bacterial Infection: A Case Report |
title_short |
“Real-Time” High-Throughput Drug and Synergy Testing for Multidrug-Resistant Bacterial Infection: A Case Report |
title_full |
“Real-Time” High-Throughput Drug and Synergy Testing for Multidrug-Resistant Bacterial Infection: A Case Report |
title_fullStr |
“Real-Time” High-Throughput Drug and Synergy Testing for Multidrug-Resistant Bacterial Infection: A Case Report |
title_full_unstemmed |
“Real-Time” High-Throughput Drug and Synergy Testing for Multidrug-Resistant Bacterial Infection: A Case Report |
title_sort |
“real-time” high-throughput drug and synergy testing for multidrug-resistant bacterial infection: a case report |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Medicine |
issn |
2296-858X |
publishDate |
2018-09-01 |
description |
Antibiotic management of infections with multidrug-resistant organisms (MDRO) represents a complex clinical challenge. We report here the first patient with a severe MDRO infection managed with assistance of a novel “real-time” 3-day high-throughput screen (HTS) that allowed screening of 9 drugs in 14 combinations in 2,304 total samplings. Identified synergies were used to modify patient therapy with the goal of reducing drug-induced toxicity. The desired clinical outcome was achieved on the HTS-informed therapeutic regimen, supporting the utility of HTS technology to expand standard antimicrobial susceptibility testing. |
topic |
multidrug-resistant organisms Klebsiella pneumoniae real-time drug test antibiotic combination therapy drug repurposing screen |
url |
https://www.frontiersin.org/article/10.3389/fmed.2018.00267/full |
work_keys_str_mv |
AT weisun realtimehighthroughputdrugandsynergytestingformultidrugresistantbacterialinfectionacasereport AT shaylahesse realtimehighthroughputdrugandsynergytestingformultidrugresistantbacterialinfectionacasereport AT miaoxu realtimehighthroughputdrugandsynergytestingformultidrugresistantbacterialinfectionacasereport AT richardwchilds realtimehighthroughputdrugandsynergytestingformultidrugresistantbacterialinfectionacasereport AT weizheng realtimehighthroughputdrugandsynergytestingformultidrugresistantbacterialinfectionacasereport AT peterrwilliamson realtimehighthroughputdrugandsynergytestingformultidrugresistantbacterialinfectionacasereport |
_version_ |
1725980595039764480 |